放疗后乳房假体置换的单中心回顾性比较研究
该单中心回顾性研究纳入2009至2021年间83例两阶段假体乳房重建后行假体置换的女性,比较放疗组(23例)与未放疗组(60例)的结局。放疗组假体置换更早、包膜挛缩更常见、术后并发症率更高(47.8% vs 18.3%,P=0.010),BREAST-Q多个维度评分显著更低;BMI和辅助化疗是放疗组术后并发症的独立预测因素。
要点
- 放疗组假体置换时间显著早于未放疗组(6.1±5.7年 vs 10.5±5.5年,P=0.001)。
- 放疗组总体术后并发症率显著更高(47.8% vs 18.3%,P=0.010)。
- BMI(OR:1.51,95%CI:1.03-2.215,P=0.034)和辅助化疗(OR:13.611,95%CI:1.127-164.33,P=0.04)是放疗组并发症独立预测因素。
核心结论
- 放疗后假体置换与并发症增加、重建失败及患者满意度降低相关。
- 应仔细选择患者,条件允许时考虑自体组织重建。
研究设计与样本
- 单中心回顾性比较研究,纳入2009至2021年间83例两阶段假体乳房重建后行假体置换的女性。
- 患者分为放疗组(n=23)和未放疗组(n=60)。
- 评估结局包括假体置换时机、手术并发症、假体失败及需二次自体重建,随访时收集BREAST-Q患者报告结局。
- 采用Logistic回归分析识别放疗组并发症的独立危险因素。
主要发现
- 放疗组假体置换更常发生于初始重建后10年内,时间显著早于未放疗组(6.1±5.7年 vs 10.5±5.5年,P=0.001)。
- 包膜挛缩是假体置换最常见指征,放疗组显著更高(P=0.002)。
- 放疗组接受更小假体(P=0.001)且更频繁进行辅助脂肪移植(P=0.018)。
- 放疗组总体术后并发症率显著更高(47.8% vs 18.3%,P=0.010)。
- 多因素Logistic回归确认BMI(OR:1.51,95%CI:1.03-2.215,P=0.034)和辅助化疗(OR:13.611,95%CI:1.127-164.33,P=0.04)为术后并发症独立预测因素。
临床怎么用
- 对放疗后需假体置换者应充分告知并发症和失败风险升高。
- 条件允许时优先考虑自体组织重建。
- 关注BMI和辅助化疗史以评估并发症风险。
局限性
- 单中心回顾性设计。
- 样本量较小(放疗组23例)。
- 辅助化疗的OR置信区间极宽(1.127-164.33),提示估计不精确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Implant-based breast reconstruction is a common procedure after mastectomy; however, postoperative radiotherapy (RT) increases the risk of developing complications such as capsular contracture, infection and implant failure. We aimed to compare the outcomes of implant replacement in irradiated versus non-irradiated patients and identify risk factors associated with complications in the RT group. METHODS: This retrospective study included 83 women who underwent implant replacement after two-stage implant-based reconstruction between 2009 and 2021. Patients were stratified into RT (n=23) and No-RT (n=60) groups. Outcomes assessed included timing of implant replacement, surgical complications, implant failure and need for secondary autologous reconstruction. BREAST-Q patient-reported outcomes were collected at the follow-up. Logistic regression analyses were conducted to identify independent risk factors for complications in RT patients. RESULTS: Implant replacement occurred most frequently within 10 years of the initial reconstruction in the RT group compared to the No-RT group (6.1±5.7 years vs 10.5±5.5 years, P=0.001). Capsular contracture was the most frequent indication for implant replacement and was significantly higher in the RT group (P=0.002). RT patients received smaller implants (P=0.001) and underwent adjunctive lipofilling more frequently (P=0.018). Overall postoperative complication rates were significantly higher among the irradiated patients (47.8% vs 18.3, P=0.010). Multivariate logistic regression confirmed BMI [OR:1.51 (95% CI:1.03-2.215, P=0.034) and adjuvant chemotherapy [OR:13.611 (95% CI: 1.127-164.33, P=0.04) as independent predictors of postoperative complications. The BREAST-Q scores were significantly lower in irradiated patients across multiple domains (P<0.05). CONCLUSIONS: Implant replacement after RT is associated with increased complications, reconstructive failure and reduced patient satisfaction. Careful patient selection is essential, and autologous reconstruction should be considered when feasible.
引用
- Starnoni M, Pappalardo M, Malmassari C, et al. Outcome of breast implant replacement after radiation therapy: A single-centre retrospective comparative study. J Plast Reconstr Aesthet Surg. 2026. PMID: 41843974. doi:10.1016/j.bjps.2026.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。